0000950170-23-068925.txt : 20231208
0000950170-23-068925.hdr.sgml : 20231208
20231208082003
ACCESSION NUMBER: 0000950170-23-068925
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231206
FILED AS OF DATE: 20231208
DATE AS OF CHANGE: 20231208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Woods Keith
CENTRAL INDEX KEY: 0001996804
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40603
FILM NUMBER: 231473970
MAIL ADDRESS:
STREET 1: C/O X4 PHARMACEUTICALS INC.
STREET 2: 61 NORTH BEACON STREET 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TScan Therapeutics, Inc.
CENTRAL INDEX KEY: 0001783328
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 825282075
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 880 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 857-399-9500
MAIL ADDRESS:
STREET 1: 880 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
ownership.xml
4
X0508
4
2023-12-06
0001783328
TScan Therapeutics, Inc.
TCRX
0001996804
Woods Keith
C/O TSCAN THERAPEUTICS, INC.
830 WINTER STREET
WALTHAM
MA
02451
true
false
false
false
false
Stock Option (Right to Buy)
6.74
2023-12-06
4
A
false
17500
0.00
A
2033-12-05
Voting Common Stock
17500
17500
D
The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) December 6, 2024 and (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service at such time.
/s/ Zoran Zdraveski, Attorney-in-Fact
2023-12-08